Cyrille J Cohen
7PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 09, 2024
Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis.Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld
|Jul 22, 2024
Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells.Vasyl Eisenberg, Shiran Hoogi, Erel Katzman
|Jul 04, 2024
Genetically engineering glycolysis in T cells increases their antitumor function.Raphaëlle Toledano Zur, Orna Atar, Tilda Barliya
|May 20, 2024
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel
|Sep 15, 2022
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis.Shlomit Kfir-Erenfeld, Nathalie Asherie, Sigal Grisariu
|May 12, 2020
Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.Sara Meril, Ortal Harush, Yishai Reboh
Pageof 2
Frequent Collaborators
3 joint publications
Eyal Lebel
3 joint publications
Nathalie Asherie
3 joint publications
Marjorie Pick
3 joint publications
Moshe E Gatt
2 joint publications
Shlomit Kfir-Erenfeld
2 joint publications
Sigal Grisariu
2 joint publications
Batia Avni
2 joint publications
Polina Stepensky
2 joint publications
Tatyana Dubnikov Sharon
1 joint publications
Shlomit Herr
